IDEXX LABORATORIES INC /DE Foreign Currency Transaction Gain (Loss), before Tax
IDEXX LABORATORIES INC /DE (IDXX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$4.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE foreign currency transaction gain (loss), before tax for fiscal 2025 was -$4.20M.
- IDEXX LABORATORIES INC /DE foreign currency transaction gain (loss), before tax for fiscal 2024 was -$4.50M.
- IDEXX LABORATORIES INC /DE foreign currency transaction gain (loss), before tax for fiscal 2023 was -$1.10M.
- IDEXX LABORATORIES INC /DE foreign currency transaction gain (loss), before tax for fiscal 2022 was -$3.40M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|
| 2025-12-31 | -$4.20M 10-K · filed 2026-02-20 |
| 2024-12-31 | -$4.50M 10-K · filed 2026-02-20 |
| 2023-12-31 | -$1.10M 10-K · filed 2026-02-20 |
| 2022-12-31 | -$3.40M 10-K · filed 2025-02-21 |
| 2021-12-31 | -$2.10M 10-K · filed 2024-02-22 |
| 2020-12-31 | $600.00K 10-K · filed 2023-02-16 |
| 2019-12-31 | -$1.10M 10-K · filed 2022-02-16 |
| 2018-12-31 | -$3.10M 10-K · filed 2021-02-12 |
| 2017-12-31 | $1.10M 10-K · filed 2020-02-14 |
| 2016-12-31 | -$1.30M 10-K · filed 2019-02-15 |
| 2015-12-31 | -$200.00K 10-K · filed 2018-02-16 |
| 2014-12-31 | -$2.00M 10-K · filed 2017-02-17 |
| 2013-12-31 | -$100.00K 10-K · filed 2016-02-17 |
| 2012-12-31 | -$200.00K 10-K · filed 2015-02-17 |
| 2011-12-31 | -$100.00K 10-K · filed 2014-02-18 |
| 2010-12-31 | -$1.00M 10-K · filed 2013-02-19 |
| 2009-12-31 | $500.00K 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |